US Federal 2025-2026 Regular Session

US Federal House Bill HB2111

Introduced
3/14/25  

Caption

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Congress_id

119-HR-2111

Policy_area

Health

Introduced_date

2025-03-14

Companion Bills

No companion bills found.

Previously Filed As

US SF1388

Certain cigars exemption from the taxes imposed on tobacco products and premium cigars

US HB1843

To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

US HF926

Sales of certain cigars exempted from the excise taxes imposed on tobacco products and premium cigars.

US SB3137

Relating To The Department Of Health's Authority To Regulate Food, Drugs, And Cosmetics.

US HB2317

Relating To The Department Of Health's Authority To Regulate Food, Drugs, And Cosmetics.

US SB255

To Amend The Definition Of "drug" Within The Food, Drug, And Cosmetic Act; And To Declare An Emergency.

US SB632

To Amend The Food, Drug, And Cosmetic Act; And To Require Warning Labels For Hair Relaxers That Contain Certain Chemicals.

US HB398

Food, drugs, and cosmetics; authorize production and sale of cottage food items with certain exemptions, requirements, and disclosures

US SF3421

Cosmetics toxics regulations provisions

US S02133

Provides that certain persons shall not be deemed a distributor for certain sales of premium cigars; provides that the tax on premium cigars shall be at the rate of seventy-five percent of the wholesale price or fifty cents, whichever is less, and is intended to be imposed only once upon the sale of any premium cigars; defines "premium cigar".

Similar Bills

US HR198

Providing for the expenses of certain committees of the House of Representatives in the One Hundred Nineteenth Congress.

MN HC1

A house concurrent resolution relating to the regent nomination joint committee.

NM HJM2

Combine Standing & Interim Committees

IL HR0020

HOUSE RULES-AMEND

CA AB1350

Employment Development Department: policies and practices.

OR SCR207

Establishing procedural rules for legislative branch.

MN HC2

A House concurrent resolution relating to the adjournment of the House of Representatives and Senate until 2026.

CA SB829

California Institute for Scientific Research: CalRx Initiative: vaccines.